Hubei Jinjian Biology Co.,Ltd of Xianning at MEDICA 2020 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

Hubei Jinjian Biology Co.,Ltd

38, Qigu Dadao, High-Tech Yangtze River Industrial Park, 437000 Xianning
China
Telephone +86 27 63496796

Contact

Amy Tian

Phone
+86-27-63496796

Email
sales@jinjianbio.com

Our range of products

Product categories

  • 03  Diagnostic tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.02  Diagnostic rapid tests

Our products

Product category: Diagnostic rapid tests

Rapid Test for COVID-19 IgG/IgM Antibody

In order to satisfy the critical, global need for serology assays that can complement nucleic acid (PCR) tests for diagnosing COVID-19 infection, Jinjian launched 2019-nCoV IgM/IgG Antibody Test Kit, which is based on the indirect immunochromatography, it is used for qualitative detection of novel coronavirus (SARS-CoV-2) IgM/IgG antibodies in human serum, plasma and venous whole blood specimen in vitro.

When you need a fast, reliable SARS-CoV-2 testing, please turn to Jinjian 2019-nCoV IgM/IgG Antibody Test Kit. Offering lab-quality results at the point of care, in a simple-to-operate and safe way, you can do it by yourself anywhere anytime, no need to be in a professional laboratory.

Benefits:

Fast and reliable results:
  • Works with 20 ul whole blood, 10ul serum or plasma.
  • Tests for both IgM and IgG antibodies.
  • Validated using PCR.
  • 10-15 minutes per test.
  • Positive results may be visible as soon as 2 minutes
Safe: Avoiding long time waiting and cross-infection.
Convenient:
No need for special equipment No need to be in a professional laboratory.
Easy: Simple operating training.
Direct: Result displayed visually.

More Less

Product category: Diagnostic rapid tests

SARS-CoV-2 Antigen Test Kit(Colloidal Gold Method)

The novel coronavirus (2019-nCoV) antigen detection kit (colloidal gold method) uses immunochromatography technology and adopts the principle of double antibody sandwich method for detection.

Rapid antigen tests perform best when the person is tested in the early stages of infection with SARS-CoV-2
when viral load is generally highest. They also may be informative in diagnostic testing situations in which
the person has a known exposure to a confirmed case of COVID-19.
Rapid antigen tests can be used for screening testing in high-risk congregate settings in which repeat testing
could quickly identify persons with a SARS-CoV-2 infection to inform infection prevention and control measures,
thus preventing transmission.

Benefits:
Rapid test within 15 min.
Easy operation
Good specificity
A short window

More Less